CD4 and metabolic syndrome: The current study only focuses on CD3+ T cells, CD4+ T cells, and CD8+ T cells, and further studies are still needed to explore the role of more types of T and B immune cells in dyslipidemia and the complex relationship between bile acid metabolism and immune cells.